Widespread expression of BORIS/CTCFL in normal and cancer cells

PLoS ONE

Volumn 6, Issue 7, 2011, Pages

  Jones, Tania A ^a   Ogunkolade, Babatunji W ^a   Szary, Jaroslaw ^a   Aarum, Johan ^a   Mumin, Muhammad A ^a   Patel, Shyam ^a   Pieri, Christopher A ^a   Sheer, Denise ^a  

^a QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

DNA BINDING PROTEIN; FIBRILLARIN; NUCLEOLIN; PROTEIN BORIS; TRANSCRIPTION FACTOR CTCF; UNCLASSIFIED DRUG; BORIS PROTEIN, MOUSE; CCCTC-BINDING FACTOR; CTCFL PROTEIN, HUMAN; NONHISTONE PROTEIN; REPRESSOR PROTEIN; SIGNAL PEPTIDE;

ANIMAL TISSUE; ARTICLE; BIOACCUMULATION; CANCER CELL; CELL NUCLEUS; CONTROLLED STUDY; CYTOPLASM; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; HUMAN TISSUE; MOUSE; NONHUMAN; NUCLEOLUS; NUCLEOTIDE SEQUENCE; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PROTEIN STRUCTURE; AMINO ACID SEQUENCE; ANIMAL; CHEMISTRY; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; MOLECULAR GENETICS; NEOPLASM; PROTEIN TRANSPORT; TUMOR CELL LINE;

AMINO ACID SEQUENCE; ANIMALS; CELL LINE, TUMOR; CELL NUCLEOLUS; CHROMOSOMAL PROTEINS, NON-HISTONE; DNA-BINDING PROTEINS; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MICE; MOLECULAR SEQUENCE DATA; NEOPLASMS; PROTEIN SORTING SIGNALS; PROTEIN TRANSPORT; REPRESSOR PROTEINS;

EID: 79960451018     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0022399     Document Type: Article

References (36)

1. Loukinov DI, Pugacheva E, Vatolin S, Pack SD, Moon H, et al. (2002) BORIS, a novel male germ-line-specific protein associated with epigenetic reprogramming events, shares the same 11-zinc-finger domain with CTCF, the insulator protein involved in reading imprinting marks in the soma. Proc Natl Acad Sci U S A 99: 6806-6811.
2. D'Arcy V, Abdullaev ZK, Pore N, Docquier F, Torrano V, et al. (2006) The potential of BORIS detected in the leukocytes of breast cancer patients as an early marker of tumorigenesis. Clin Cancer Res 12: 5978-5986.
3. D'Arcy V, Pore N, Docquier F, Abdullaev ZK, Chernukhin I, et al. (2008) BORIS, a paralogue of the transcription factor, CTCF, is aberrantly expressed in breast tumours. Br J Cancer 98: 571-579.
4. Dougherty CJ, Ichim TE, Liu L, Reznik G, Min WP, et al. (2008) Selective apoptosis of breast cancer cells by siRNA targeting of BORIS. Biochem Biophys Res Commun 370: 109-112.
5. Hoffmann MJ, Muller M, Engers R, Schulz WA, (2006) Epigenetic control of CTCFL/BORIS and OCT4 expression in urogenital malignancies. Biochem Pharmacol 72: 1577-1588.
6. Hong JA, Kang Y, Abdullaev Z, Flanagan PT, Pack SD, et al. (2005) Reciprocal binding of CTCF and BORIS to the NY-ESO-1 promoter coincides with derepression of this cancer-testis gene in lung cancer cells. Cancer Res 65: 7763-7774.
7. Kholmanskikh O, Loriot A, Brasseur F, De Plaen E, De Smet C, (2008) Expression of BORIS in melanoma: lack of association with MAGE-A1 activation. Int J Cancer 122: 777-784.
8. Looijenga LH, Hersmus R, Gillis AJ, Pfundt R, Stoop HJ, et al. (2006) Genomic and expression profiling of human spermatocytic seminomas: primary spermatocyte as tumorigenic precursor and DMRT1 as candidate chromosome 9 gene. Cancer Res 66: 290-302.
9. Risinger JI, Chandramouli GV, Maxwell GL, Custer M, Pack S, et al. (2007) Global expression analysis of cancer/testis genes in uterine cancers reveals a high incidence of BORIS expression. Clin Cancer Res 13: 1713-1719.
10. Ulaner GA, Vu TH, Li T, Hu JF, Yao XM, et al. (2003) Loss of imprinting of IGF2 and H19 in osteosarcoma is accompanied by reciprocal methylation changes of a CTCF-binding site. Hum Mol Genet 12: 535-549.
11. Vatolin S, Abdullaev Z, Pack SD, Flanagan PT, Custer M, et al. (2005) Conditional expression of the CTCF-paralogous transcriptional factor BORIS in normal cells results in demethylation and derepression of MAGE-A1 and reactivation of other cancer-testis genes. Cancer Res 65: 7751-7762.
12. Woloszynska-Read A, James SR, Link PA, Yu J, Odunsi K, et al. (2007) DNA methylation-dependent regulation of BORIS/CTCFL expression in ovarian cancer. Cancer Immun 7: 21.
13. Hines WC, Bazarov AV, Mukhopadhyay R, Yaswen P, (2010) BORIS (CTCFL) is not expressed in most human breast cell lines and high grade breast carcinomas. PLoS One 5: e9738.
14. Woloszynska-Read A, Zhang W, Yu J, Link PA, Mhawech-Fauceglia P, et al. (2011) Coordinated cancer germline antigen promoter and global DNA hypomethylation in ovarian cancer: association with BORIS/CTCF expression ratio and advanced stage. Clin Cancer Res.
15. Hore TA, Deakin JE, Marshall Graves JA, (2008) The evolution of epigenetic regulators CTCF and BORIS/CTCFL in amniotes. PLoS Genet 4: e1000169.
16. Campbell AE, Martinez SR, Miranda JJ, (2010) Molecular architecture of CTCFL. Biochem Biophys Res Commun 396: 648-650.
17. Klenova EM, Morse HC 3rd, Ohlsson R, Lobanenkov VV, (2002) The novel BORIS + CTCF gene family is uniquely involved in the epigenetics of normal biology and cancer. Semin Cancer Biol 12: 399-414.
18. Kang Y, Hong JA, Chen GA, Nguyen DM, Schrump DS, (2007) Dynamic transcriptional regulatory complexes including BORIS, CTCF and Sp1 modulate NY-ESO-1 expression in lung cancer cells. Oncogene 26: 4394-4403.
19. Pugacheva EM, Suzuki T, Pack SD, Kosaka-Suzuki N, Yoon J, et al. (2010) The Structural Complexity of the Human BORIS Gene in Gametogenesis and Cancer. PLoS One 5: e13872.
20. Klenova E, Ohlsson R, (2005) Poly(ADP-ribosyl)ation and epigenetics. Is CTCF PARt of the plot? Cell Cycle 4: 96-101.
21. Maier T, Guell M, Serrano L, (2009) Correlation of mRNA and protein in complex biological samples. FEBS Lett 583: 3966-3973.
22. Chen G, Gharib TG, Huang CC, Taylor JM, Misek DE, et al. (2002) Discordant protein and mRNA expression in lung adenocarcinomas. Mol Cell Proteomics 1: 304-313.
23. Kim SK, Srivastava M, (2003) Stability of Nucleolin protein as the basis for the differential expression of Nucleolin mRNA and protein during serum starvation. DNA Cell Biol 22: 171-178.
24. Boisvert FM, van Koningsbruggen S, Navascues J, Lamond AI, (2007) The multifunctional nucleolus. Nat Rev Mol Cell Biol 8: 574-585.
25. Mongelard F, Bouvet P, (2007) Nucleolin: a multiFACeTed protein. Trends Cell Biol 17: 80-86.
26. Scott MS, Boisvert FM, McDowall MD, Lamond AI, Barton GJ, (2010) Characterization and prediction of protein nucleolar localization sequences. Nucleic Acids Res 38: 7388-7399.
27. Torrano V, Navascues J, Docquier F, Zhang R, Burke LJ, et al. (2006) Targeting of CTCF to the nucleolus inhibits nucleolar transcription through a poly(ADP-ribosyl)ation-dependent mechanism. J Cell Sci 119: 1746-1759.
28. van de Nobelen S, Rosa-Garrido M, Leers J, Heath H, Soochit W, et al. (2010) CTCF regulates the local epigenetic state of ribosomal DNA repeats. Epigenetics Chromatin 3: 19.
29. Chen D, Huang S, (2001) Nucleolar components involved in ribosome biogenesis cycle between the nucleolus and nucleoplasm in interphase cells. J Cell Biol 153: 169-176.
30. Andersen JS, Lyon CE, Fox AH, Leung AK, Lam YW, et al. (2002) Directed proteomic analysis of the human nucleolus. Curr Biol 12: 1-11.
31. Bartova E, Horakova AH, Uhlirova R, Raska I, Galiova G, et al. (2010) Structure and epigenetics of nucleoli in comparison with non-nucleolar compartments. J Histochem Cytochem 58: 391-403.
32. Raska I, Koberna K, Malinsky J, Fidlerova H, Masata M, (2004) The nucleolus and transcription of ribosomal genes. Biol Cell 96: 579-594.
33. Andersen JS, Lam YW, Leung AK, Ong SE, Lyon CE, et al. (2005) Nucleolar proteome dynamics. Nature 433: 77-83.
34. Sirri V, Urcuqui-Inchima S, Roussel P, Hernandez-Verdun D, (2008) Nucleolus: the fascinating nuclear body. Histochem Cell Biol 129: 13-31.
35. Bustin SA, (2000) Absolute quantification of mRNA using real-time reverse transcription polymerase chain reaction assays. J Mol Endocrinol 25: 169-193.
36. Klenova EM, Nicolas RH, Paterson HF, Carne AF, Heath CM, et al. (1993) CTCF, a conserved nuclear factor required for optimal transcriptional activity of the chicken c-myc gene, is an 11-Zn-finger protein differentially expressed in multiple forms. Mol Cell Biol 13: 7612-7624.